AMILI
Precision gut microbiome diagnostics and FMT bank; largest multi-ethnic Asian microbiome database
AMILI is Southeast Asia's leading precision gut microbiome company, founded in Singapore in 2019, and runs the region's only microbiome transplant bank. It offers clinical gut health testing, microbiome restoration therapy, AI-powered analytics for healthcare partners, and physician-guided probiotic programs, and holds the world's largest multi-ethnic Asian gut microbiome database. Backed by Vulcan Capital and East Ventures, it collaborates with NUS, NUH, and Monash University.


















